Paper · 35967289

Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma.

Tang H and 11 others. Acta Pharm Sin B, 2022. Cited by 34 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma. Papers, record 35967289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35967289

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma.; PubMed
Journal: Acta Pharm Sin B; PubMed
Year: 2022; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/35967289/; PubMed
DOI: https://doi.org/10.1016/j.apsb.2022.02.007; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC9366227/; PubMed
The journal: https://conductscience.org/library/journal-index/101600560; PubMed
Citations, by iCite: 34; iCite
Relative citation ratio, by iCite: 2.55; iCite
Revised in PubMed: 2022-08-16; PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Tang H	Honglin
2	Xue Y	Yanan
3	Li B	Bowen
4	Xu X	Xiaojie
5	Zhang F	Fu
6	Guo J	Jiajing
7	Li Q	Qijun
8	Yuan T	Tingting
9	Chen Y	Yuan
10	Pan Y	Yubin

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	17,452,677	Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.	J Clin Oncol	2007	https://conductscience.org/library/papers/17452677	PubMed
2	24,170,548	Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity.	Clin Cancer Res	2014	https://conductscience.org/library/papers/24170548	PubMed
3	28,993,833	Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?	Cell Mol Life Sci	2018	https://conductscience.org/library/papers/28993833	PubMed
4	29,651,130	Targeting the tumour stroma to improve cancer therapy.	Nat Rev Clin Oncol	2018	https://conductscience.org/library/papers/29651130	PubMed
5	31,120,501	Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial.	JAMA Oncol	2019	https://conductscience.org/library/papers/31120501	PubMed
6	32,499,547	An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.	Nat Commun	2020	https://conductscience.org/library/papers/32499547	PubMed
7	33,546,284	Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer.	Cancers (Basel)	2021	https://conductscience.org/library/papers/33546284	PubMed
8	33,210,947	Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver.	J Drug Target	2021	https://conductscience.org/library/papers/33210947	PubMed
9	30,676,760	Enhanced Drug Delivery by Nanoscale Integration of a Nitric Oxide Donor To Induce Tumor Collagen Depletion.	Nano Lett	2019	https://conductscience.org/library/papers/30676760	PubMed
10	29,386,069	Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.	J Hematol Oncol	2018	https://conductscience.org/library/papers/29386069	PubMed

1 to 10 of 48

See all 48 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMID	Title	Journal	Year	In Papers	Source
42,312,159	Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy.	ACS Pharmacol Transl Sci	2026	https://conductscience.org/library/papers/42312159	PubMed
42,294,061	Signaling pathway mechanisms in pancreatic ductal adenocarcinoma tumor microenvironment and emerging targeting strategies for improved prognosis.	Oncol Rev	2026	https://conductscience.org/library/papers/42294061	PubMed
42,218,726	Current advances in immunotherapy for KRAS-Mutant pancreatic cancer.	Clin Exp Med	2026	https://conductscience.org/library/papers/42218726	PubMed
41,869,550	Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer.	Smart Mater Med	2025	https://conductscience.org/library/papers/41869550	PubMed
41,674,408	A Reproducible Workflow for Macrophage Membrane Isolation and Nanocore Selection Toward Bioinspired Nanoparticles Targeting Immunologically Cold Tumors.	Small Methods	2026	https://conductscience.org/library/papers/41674408	PubMed
41,421,661	Assembly delivery of bioactive matters: Advances, challenges, and prospects.	J Adv Res	2026	https://conductscience.org/library/papers/41421661	PubMed
41,293,487	Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer.	Mater Today Bio	2025	https://conductscience.org/library/papers/41293487	PubMed
40,708,975	Biomembrane-coated nanosystems as next-generation delivery systems for the treatment of gastrointestinal cancers.	Bioeng Transl Med	2025	https://conductscience.org/library/papers/40708975	PubMed
40,225,567	Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy.	Theranostics	2025	https://conductscience.org/library/papers/40225567	PubMed
40,182,139	Pancreatic Cancer: Pathogenesis and Clinical Studies.	MedComm (2020)	2025	https://conductscience.org/library/papers/40182139	PubMed

1 to 10 of 21

See all 21 cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
ACTA1	58	PubTator's text mining	https://conductscience.org/library/genes/58	NCBI Gene
ANXA5	308	PubTator's text mining	https://conductscience.org/library/genes/308	NCBI Gene
CD14	929	PubTator's text mining	https://conductscience.org/library/genes/929	NCBI Gene
CDH1	999	PubTator's text mining	https://conductscience.org/library/genes/999	NCBI Gene
EGFR	1,956	PubTator's text mining	https://conductscience.org/library/genes/1956	NCBI Gene
ERBB2	2,064	PubTator's text mining	https://conductscience.org/library/genes/2064	NCBI Gene
EREG	2,069	PubTator's text mining	https://conductscience.org/library/genes/2069	NCBI Gene
FLT3	2,322	PubTator's text mining	https://conductscience.org/library/genes/2322	NCBI Gene
IL1B	3,553	PubTator's text mining	https://conductscience.org/library/genes/3553	NCBI Gene
IRAK4	51,135	PubTator's text mining	https://conductscience.org/library/genes/51135	NCBI Gene

1 to 10 of 15

See all 15 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35967289

GET https://conductscience.org/api/papers/v1/35967289/references?page=2

API reference For AI assistants